MedTrace Logo

Prevalence and Burden of Bronchiectasis in Tuberculous Patients

NCT04085133 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2023-02-17

No results posted yet for this study

Summary

Bronchiectasis was described in the early 19th century by Laennec. Bronchiectasis is a chronic condition characterized by permanent and irreversible dilatation of the bronchial airways and impairment of mucociliary transport mechanism due to repeated infection and inflammation leading to colonization of organism and pooling of the mucus in the bronchial tree

Conditions

  • Pulmonary Tuberculoses

Interventions

DIAGNOSTIC_TEST

Gene Xpert Chest x ray and MSCT chest

Sputum sample for T.B will be done using gene expert device and chest xray and high resolution ct to evaluate bronchectasis

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-26
Primary Completion
2020-01-01
Completion
2020-04-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04085133 on ClinicalTrials.gov